Ayana U. (2007). Risk Evaluation of Liver Cirrhosis and Hepatocellular Carcinoma Using AFP,HBeAg. Anti HBe and SGPT as Markers in Chronic Hepatitis B Patients. Aswini Diagnostic Services.
Chicago Edition CitationAyana U. Risk Evaluation of Liver Cirrhosis and Hepatocellular Carcinoma Using AFP,HBeAg. Anti HBe and SGPT as Markers in Chronic Hepatitis B Patients. Calicut: Aswini Diagnostic Services, 2007.
Cita MLAAyana U. Risk Evaluation of Liver Cirrhosis and Hepatocellular Carcinoma Using AFP,HBeAg. Anti HBe and SGPT as Markers in Chronic Hepatitis B Patients. Aswini Diagnostic Services, 2007.
Atenció: Aquestes cites poden no estar 100% correctes.